Postoperative atrial fibrillation in liver transplantation

American Journal of Transplantation

Volumn 15, Issue 3, 2015, Pages 687-694

  Xia, Victor W ^a   Worapot, A ^a,b   Huang, S ^a,c   Dhillon, A ^a   Gudzenko, V ^a   Backon, A ^a   Agopian, V G ^a   Aksoy, O ^a   Vorobiof, G ^a   Busuttil, R W ^a   Steadman, R H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c BEIJING HOSPITAL   (China)

Author keywords

cardiology; cardiovascular disease; clinical research; complication; critical care; heart transplantation; hepatology; intensive care management; liver transplantation; practice

Indexed keywords

HYPERTENSIVE FACTOR;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; COHORT ANALYSIS; DIASTOLIC BLOOD PRESSURE; FEMALE; GRAFT FAILURE; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; LIVER TRANSPLANTATION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; POSTOPERATIVE ATRIAL FIBRILLATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; ADVERSE EFFECTS; ATRIAL FIBRILLATION; MIDDLE AGED;

ADULT; ATRIAL FIBRILLATION; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS;

EID: 84923294964     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.13034     Document Type: Article

References (36)

1. January CT, Wann LS, Alpert JS, et al. AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014; pii: S0735-1097(14)01740-9. doi: 10.1016/j.jacc.2014.03.022 [Epub ahead of print].
2. Maesen B, Nijs J, Maessen J, Allessie M, Schotten U., Post-operative atrial fibrillation: A maze of mechanisms. Europace 2012; 14: 159-174.
3. Tokmaji G, McClure RS, Kaneko T, Aranki SF., Management strategies in cardiac surgery for postoperative atrial fibrillation: Contemporary prophylaxis and futuristic anticoagulant possibilities. Cardiol Res Pract 2013; 2013: 637482.
4. Bansal N, Fan D, Hsu CY, Ordonez JD, Marcus GM, Go AS., Incident atrial fibrillation and risk of end-stage renal disease in adults with chronic kidney disease. Circulation 2013; 127: 569-574.
5. Bhave PD, Goldman LE, Vittinghoff E, Maselli J, Auerbach A., Incidence, predictors, and outcomes associated with postoperative atrial fibrillation after major noncardiac surgery. Am Heart J 2012; 164: 918-924.
6. Vannucci A, Rathor R, Vachharajani N, Chapman W, Kangrga I., Atrial fibrillation in patients undergoing liver transplantation-a single-center experience. Transplant Proc 2014; 46: 1432-1437.
7. Bargehr J, Trejo-Gutierrez JF, Rosser BG, et al. Liver transplantation in patients with atrial fibrillation. Transplant Proc 2013; 45: 2302-2306.
8. Alonso A, Misialek JR, Amiin MA, et al. Circulating levels of liver enzymes and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities cohort. Heart 2014; 100: 1511-1516.
9. Johnston SD, Morris JK, Cramb R, Gunson BK, Neuberger J., Cardiovascular morbidity and mortality after orthotopic liver transplantation. Transplantation 2002; 73: 901-906.
10. Ali A, Bhardwaj HL, Heuman DM, Jovin IS., Coronary events in patients undergoing orthotopic liver transplantation: Perioperative evaluation and management. Clin Transplant 2013; 27: E207-E215.
11. Murray PT, Mehta RL, Shaw A, et al. Potential use of biomarkers in acute kidney injury: Report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int 2014; 85: 513-521.
12. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative Workgroup. Acute renal failure-definition, outcome measures, animal models, fluid therapy and information technology needs: The Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004; 8: R204-R212.
13. Shen J, Lall S, Zheng V, Buckley P, Damiano RJ Jr, Schuessler RB., The persistent problem of new-onset postoperative atrial fibrillation: A single-institution experience over two decades. J Thorac Cardiovasc Surg 2011; 141: 559-570.
14. Onaitis M, D'Amico T, Zhao Y, O'Brien S, Harpole D., Risk factors for atrial fibrillation after lung cancer surgery: Analysis of the Society of Thoracic Surgeons general thoracic surgery database. Ann Thorac Surg 2010; 90: 368-374.
15. Burris JM, Subramanian A, Sansgiry S, Palacio CH, Bakaeen FG, Awad SS., Perioperative atrial arrhythmias in noncardiothoracic patients: A review of risk factors and treatment strategies in the veteran population. Am J Surg 2010; 200: 601-605.
16. La Manna G, Boriani G, Capelli I, et al. Incidence and predictors of postoperative atrial fibrillation in kidney transplant recipients. Transplantation 2013; 96: 981-986.
17. Hernandez AV, Kaw R, Pasupuleti V, et al. Association between obesity and postoperative atrial fibrillation in patients undergoing cardiac operations: A systematic review and meta-analysis. Ann Thorac Surg 2013; 96: 1104-1116.
18. Xia VW, Taniguchi M, Steadman RH., The changing face of patients presenting for liver transplantation. Curr Opin Organ Transplant 2008; 13: 280-284.
19. Polanczyk CA, Goldman L, Marcantonio ER, Orav EJ, Lee TH., Supraventricular arrhythmia in patients having noncardiac surgery: Clinical correlates and effect on length of stay. Ann Intern Med 1998; 129: 279-285.
20. Xia VW, Du B, Braunfeld M, et al. Preoperative characteristics and intraoperative transfusion and vasopressor requirements in patients with low vs. high MELD scores. Liver Transpl 2006; 12: 614-620.
21. Jons C, Joergensen RM, Hassager C, et al. Diastolic dysfunction predicts new-onset atrial fibrillation and cardiovascular events in patients with acute myocardial infarction and depressed left ventricular systolic function: A CARISMA substudy. Eur J Echocardiogr 2010; 11: 602-607.
22. Wann LS, Curtis AB, January CT, et al. ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011; 57: 223-242.
23. Rodrigo R., Prevention of postoperative atrial fibrillation: Novel and safe strategy based on the modulation of the antioxidant system. Front Physiol 2012; 3: 93.
24. Tisdale JE, Wroblewski HA, Wall DS, et al. A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection. Ann Thorac Surg 2009; 88: 886-893.
25. Tisdale JE, Wroblewski HA, Kesler KA., Prophylaxis of atrial fibrillation after noncardiac thoracic surgery. Semin Thorac Cardiovasc Surg 2010; 22: 310-320.
26. Koniari I, Apostolakis E, Rogkakou C, Baikoussis NG, Dougenis D., Pharmacologic prophylaxis for atrial fibrillation following cardiac surgery: A systematic review. J Cardiothorac Surg 2010; 5: 121.
27. London MJ, Hur K, Schwartz GG, Henderson WG., Association of perioperative beta-blockade with mortality and cardiovascular morbidity following major noncardiac surgery. JAMA 2013; 309: 1704-1713.
28. Rosanio S, Keylani AM, D'Agostino DC, DeLaughter CM, Vitarelli A., Pharmacology, benefits, unaddressed questions, and pragmatic issues of the newer oral anticoagulants for stroke prophylaxis in non-valvular atrial fibrillation and proposal of a management algorithm. Int J Cardiol 2014; 174: 471-483.
29. Bhave PD, Goldman LE, Vittinghoff E, Maselli JH, Auerbach A., Statin use and postoperative atrial fibrillation after major noncardiac surgery. Heart Rhythm 2012; 9: 163-169.
30. Chopra V, Wesorick DH, Sussman JB, et al. Effect of perioperative statins on death, myocardial infarction, atrial fibrillation, and length of stay: A systematic review and meta-analysis. Arch Surg 2012; 147: 181-189.
31. Liu XH, Xu CY, Fan GH., Efficacy of N-acetylcysteine in preventing atrial fibrillation after cardiac surgery: A meta-analysis of published randomized controlled trials. BMC Cardiovasc Disord 2014; 14: 52.
32. Bansal N, Hsu CY, Go AS., Intersection of cardiovascular disease and kidney disease: Atrial fibrillation. Curr Opin Nephrol Hypertens 2014; 23: 275-282.
33. Raja K, Thung SN, Fiel MI, Chang C., Drug-induced steatohepatitis leading to cirrhosis: Long-term toxicity of amiodarone use. Semin Liver Dis 2009; 29: 423-428.
34. Cho Y, Lee MJ, Choe EY, et al. Statin therapy is associated with the development of new-onset diabetes after transplantation in liver recipients with high fasting plasma glucose levels. Liver Transpl 2014; 20: 557-563.
35. Leise MD, Poterucha JJ, Talwalkar JA., Drug-induced liver injury. Mayo Clin Proc 2014; 89: 95-106.
36. von Vital JM, Karachristos A, Singhal A, Thomas R, Jain A., Acute amiodarone hepatotoxicity after liver transplantation. Transplantation 2011; 91: e62-e64.